Hypoxia, drug therapy and toxicity
- 1 February 2007
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 113 (2) , 229-246
- https://doi.org/10.1016/j.pharmthera.2006.08.001
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Induction of the nuclear factor HIF-1α in acetaminophen toxicity: Evidence for oxidative stressBiochemical and Biophysical Research Communications, 2006
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005
- Adverse hepatic drug reactions: inflammatory episodes as consequence and contributorChemico-Biological Interactions, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cellsBiochemical and Biophysical Research Communications, 2003
- Dibenzoylmethane, a natural dietary compound, induces HIF-1α and increases expression of VEGFBiochemical and Biophysical Research Communications, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- In Vivo Potentiation of Glutamate-Mediated Neuronal Damage after Chronic Administration of the Glycolysis Inhibitor IodoacetateExperimental Neurology, 2000
- An Association between Collateral Blood Flow and Myocardial Viability in Patients with Recent Myocardial InfarctionNew England Journal of Medicine, 1992
- On the Origin of Cancer CellsScience, 1956